DPNCheck Logo

Biomedix Signs Collaboration Agreement with NeuroMetrix DPNCheck

WOBURN, Mass., June 25, 2020 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has signed a collaboration agreement with Biomedix to comarket DPNCheck for peripheral neuropathy detection within Medicare Advantage and other value-based care markets.  NeuroMetrix and Biomedix provide complementary diagnostic tests to physicians and health plans. Read more…

COVID-19

COVID-19 & Biomedix

We appreciate that many of you are experiencing unprecedented circumstances due to COVID-19. This is our first communication regarding this rapidly-developing situation, as we’ve spent the last week developing ways to assist as many of our customers in these unusual times. Please note that not all of these options may Read more…